4//SEC Filing
ENZO BIOCHEM INC 4
Accession 0000914760-16-000389
CIK 0000316253operating
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 2:41 PM ET
Size
14.1 KB
Accession
0000914760-16-000389
Insider Transaction Report
Form 4
KASTEN BERNARD L
Director
Transactions
- Sale
Common Stock
2016-03-10$4.40/sh−1,857$8,171→ 38,425 total - Sale
Common Stock
2016-03-10$4.40/sh−9,720$42,739→ 28,705 total - Sale
Common Stock
2016-03-11$4.39/sh−3,100$13,597→ 6,954 total - Sale
Common Stock
2016-01-21$4.66/sh−2,500$11,640→ 40,282 total - Sale
Common Stock
2016-03-10$3.47/sh−18,651$64,644→ 10,054 total - Sale
Common Stock
2016-03-11$4.41/sh−6,954$30,674→ 0 total - Award
Stock Option (to acquire common stock)
2016-01-06+63,291→ 257,455 totalExercise: $4.66From: 2017-01-07Exp: 2021-01-05→ Common Stock (63,291 underlying)
Footnotes (1)
- [F1]The Reporting Person was granted 63,291 stock options. The options have a five-year term and shall vest in two equal annual tranches, beginning January 7, 2017.
Documents
Issuer
ENZO BIOCHEM INC
CIK 0000316253
Entity typeoperating
IncorporatedNY
Related Parties
1- filerCIK 0000316253
Filing Metadata
- Form type
- 4
- Filed
- Mar 17, 8:00 PM ET
- Accepted
- Mar 18, 2:41 PM ET
- Size
- 14.1 KB